The Swedish biotech hopes its precision therapy will help patients with advanced solid tumors who currently have few ...

The French biotech company Nanobiotix announced today that it has dosed the first patient in the CONVERGE study, a Phase 2 ...

Josh Gissing is Cluster Head (UK, Ireland & Nordics) for Biocon Biologics: a biosimilars company whose business model seeks ...

As Director of R&D at Sunflower Therapeutics, Laura Crowell works with a team developing biologic medicines and vaccines. She ...

Diane Lacroix, Vice President of Clinical Data Management at eClinical Solutions, talks personalised medicine, data decisions ...

The oversubscribed Series C financing round will support the clinical development of in vivo CAR-T cells for oncology and ...

The US biotech aims to bring its antibody-based therapies to human trials later in the year and to develop new candidate ...